References

  1. Van Damme L, Govinden R, Mirembe FM, Guédou F, Solomon S, Becker ML, Pradeep BS, Krishnan AK, Alary M, Pande B, Ramjee G, Deese J, Crucitti T, Taylor D, CS Study Group: Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission.

    N Engl J Med 2008 , 359:463-472. PubMed Abstract | Publisher Full Text OpenURL

  2. Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos MG, Friedland B, Govender S, De Kock A, Cassim N, Palanee T, Dozier G, Maguire R, Lahteenmaki P: Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.

    Lancet 2008 , 372:1977-87. PubMed Abstract | Publisher Full Text OpenURL

  3. Abdool Karim S, Coletti A, Richardson B, Ramjee G, Hoffman I, Chirenje M, Taha T, Kapina M, Maslankowski L, Soto-Torres L: Safety and effectiveness of vaginal microbicides BufferGel and 0.5% PRO 2000/5 gel for the prevention of HIV infection in women: results of the HPTN 035 Trial. [http://www.retroconference.org/2009/Abstracts/36659.htm]

    16th Conference on Retroviruses and Opportunistics Infections. Montreal, QC, CANADA 2009. OpenURL

  4. Cutler B, Justman J: Vaginal microbicides and the prevention of HIV transmission.

    Lancet Infect Dis 2008 , 8:685-97. PubMed Abstract | Publisher Full Text OpenURL

  5. Desai K: How reliable does self-reported sex behaviour need to be for valid microbicide efficacy estimation?

    Microbicides 2004, London, UK 2004. OpenURL

  6. Desai K, Boily MC, Garnett K: Ensuring phase III microbicide trials against HIV adequately estimate treatment efficacy: guidance from dynamical models.

    Meeting of the International Society of Sexually Transmitted Diseases Research (ISSTDR) 2003. OpenURL

  7. Weiss HA, Wasserheit JN, Barnabas RV, Hayes RJ, Abu-Raddad LJ: Persisting with prevention: The importance of adherence for HIV prevention.

    Emerging Themes in Epidemiology 2008 , 5:8. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL

  8. Rottingen JA, Garnett GP: The epidemiological and control implications of HIV transmission probabilities within partnerships.

    Sex Transm Dis 2002 , 29:818-27. PubMed Abstract | Publisher Full Text OpenURL

  9. Raymond EG, Taylor D, Cates W Jr, Tolley EE, Borasky D, Cancel A, Mâsse B, Bukusi EA, Johnson BR: Pregnancy in effectiveness trials of HIV prevention agents.

    Sex Transm Dis 2007 , 34(12):1035-9. PubMed Abstract | Publisher Full Text OpenURL

  10. Mosher WD, Chandra A, Jones J: Sexual behavior and selected health measures: men and women 15-44 years of age.

    Advance Data from Vital and Health Statistics, Center for Diseases Control 2005. , 362: OpenURL

  11. Lane T, Pettifor A, Pascoe S, Fiamma A, Rees H: Heterosexual anal intercourse increases risk of HIV infection among young South African men.

    AIDS 2006 , 20(1):123-5. PubMed Abstract | Publisher Full Text OpenURL

  12. Wallace AR, Teitelbaum A, Wan L, Mulima MG, Guichard L, Skoler S, Vilakazi H, Mapula FS, Rossier J, Govender SN, Lahteenmaki P, Maguire RA, Phillips DM: Determining the feasibility of utilizing the microbicide applicator compliance assay for use in clinical trials.

    Contraception 2007 , 76:53-6. PubMed Abstract | Publisher Full Text OpenURL

  13. Kilmarx P, Paxton L: Need for a true placebo for vaginal microbicide efficacy trials.

    Lancet 2003 , 361:785-6. PubMed Abstract | Publisher Full Text OpenURL

  14. Trussell J, Dominik R: Will microbicide trials yield unbiased estimates of microbicide efficacy?

    Contraception 2005 , 72(6):408-13. PubMed Abstract | Publisher Full Text OpenURL

    Epub 2005 Aug 24

  15. Cates W, Feldblum P: HIV prevention research: the ecstasy and the agony.

    Lancet 2008 , 372:1932-3. PubMed Abstract | Publisher Full Text OpenURL

  16. Van Damme L, Ramjee G, Alary M, Vuylsteke B, Chandeying V, Rees H, Sirivongrangson P, Mukenge-Tshibaka L, Ettiègne-Traore V, Uaheowitchai C, Karim S, Mâsse B, Perriens J, Laga M: Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomized controlled trial.

    Lancet 2002 , 360:971-977. PubMed Abstract | Publisher Full Text OpenURL

  17. Roddy RE, Zekeng L, Ryan KA, Tamoufe U, Weir SS, Wong EL: A controlled trial of nonoxynol-9 film to reduce male-to-female transmission of sexually transmitted diseases.

    N Engl J Med 1998 , 339:504-510. PubMed Abstract | Publisher Full Text OpenURL

  18. Peterson L, Nanda K, Opoku BK, Ampofo WK, Owusu-Amoako M, Boakye AY, Rountree W, Troxler A, Dominik R, Roddy R, Dorflinger L: SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana.

    PLoS ONE 2007 , 2(12):e1312. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  19. Feldblum PJ, Adeiga A, Bakare R, Wevill S, Lendvay A, Obadaki F, Olayemi MO, Wang L, Nanda K, Rountree W: Savvy vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria.

    PLoS One 2008 , 3:e1474. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  20. Halpern V, Ogunsola F, Obunge O, Wang CH, Onyejepu N, Oduyebo O, Taylor D, McNeil L, Mehta N, Umo-Otong J, Otusanya S, Crucitti T, Abdellati S: Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria.

    PLoS ONE 2008 , 3(11):e3784. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  21. Foulkes MA, Lachin JM: Sample size and power for survival time studies with nonuniform entry, losses to follow-up, noncompliance, and stratification.

    Controlled Clinical Trials 1985 , 6(3):230. Publisher Full Text OpenURL